Cell Therapy Associated With Endobronchial Valve

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

November 19, 2019

Primary Completion Date

August 17, 2020

Study Completion Date

April 30, 2029

Conditions
Chronic Obstructive Pulmonary Disease Severe
Interventions
DEVICE

Zephyr Endobronchial Valve

Endoscopic lung volume reduction therapy.

BIOLOGICAL

Marrow-derived mesenchymal stromal cell

Mesenchymal stem cells have anti-inflammatory, anti-fibrotic, microbicide and repair potential.

Trial Locations (1)

90035903

RECRUITING

Hospital de Clinicas de Porto Alegre, Porto Alegre

All Listed Sponsors
collaborator

Pontifícia Universidade Católica do Paraná

OTHER

collaborator

Universidade Federal do Rio de Janeiro

OTHER

lead

Hospital de Clinicas de Porto Alegre

OTHER